real-world outcomes of patients with r/r b-all treated with blinatumomab and inotuzumab ozogamicin
Published 1 year ago • 170 plays • Length 4:13Download video MP4
Download video MP3
Similar videos
-
1:35
outcomes of allosct following blinatumomab in children and young adults with r/r b-all
-
1:43
real-world outcomes of teclistamab for r/r multiple myeloma
-
3:03
outcomes following venetoclax monotherapy in patients with r/r wm in the real-world setting
-
2:17
insights into the real-world efficacy of luspatercept in patients with lr-mds
-
6:38
real-world efficacy & safety of teclistamab in patients with heavily pretreated r/r multiple myeloma
-
1:50
real-world outcomes of teclistamab treatment in r/r multiple myeloma
-
3:17
insights into the health-related quality of life of patients with hemophilia
-
1:13
monitoring patients with cll on ibrutinib-based therapies
-
1:30
outcomes in rrmm treated with ird in the real world
-
1:33
real-world multicenter study of caplacizumab in patients with acquired ttp
-
1:45
long-term survival of patients with cll treated with ibrutinib compared to age-matched controls
-
0:42
quality of life with octocog alfa in patients with hemophilia a: read-out of the ahead study
-
1:55
long-term real-world experience of cpx-351 in patients with t-aml and mrc-aml
-
0:56
real-world survival in patients with mixed phenotype attr-cm treated with tafamidis
-
2:47
real-world data on the safety of emicizumab in patients with hemophilia a
-
3:02
the effects of maintenance therapy on real-world outcomes for patients with ndmm
-
5:05
outcomes of allohct in adults with ph-like all
-
1:17
using an ai model to quantify under-utilization of allosct for aml in the uk
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml